These final results, along with a former report displaying that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 guidance the thought of targeting ACKR3 as a unique way to modulate the opioid process, which could open new therapeutic avenues for opioid-related disorders. By ticking this box and https://hansn912cwu5.dailyblogzz.com/profile